경제
중도 성향
AbbVie would gain an experimental eczema drug by buying biotech: report
MarketWatch
조회 0
AbbVie is reportedly trying to buy a biotech company that is developing a promising atopic dermatitis drug for $10.9 billion in cash, according to a Financial Times report. ...
이 뉴스, 독자들은 어떻게 느꼈나요?
첫 반응을 남겨보세요로그인하면 감정 반응에 참여할 수 있어요.
관련 뉴스
관련 뉴스 제보는 로그인 후 가능합니다.
'economy' 카테고리 뉴스
MarketWatch의 다른 기사
The initial SpaceX frenzy is cooling off — but a new wave of cash is waiting to strike
MarketWatch
‘Money can make you happy’: My wife and I have no heirs, but we’re making the world a better place by giving it away
MarketWatch
Google shake-up highlights how human brains may be the scarcest AI resource of all
MarketWatch